A theme aimed at acquiring the technology and business platform related to single-cell analysis and next-generation sequencing library preparation instruments through the acquisition of WaferGen Bio-systems, with a view to advancing research and development and expanding the business. Following the acquisition, the related business also incurred impairment losses and inventory valuation losses.